https://hebias.be/ https://hebias.be/the-value-of-a-proven-price-structure/ 2026-10-01T14:42:45+02:00 https://hebias.be/health-gain/ 2026-10-01T14:42:45+02:00 https://hebias.be/why-patient-engagement-is-essential-for-market-access-of-medical-innovation-in-belgium-2/ 2026-10-01T14:42:45+02:00 https://hebias.be/incidence-versus-prevalence-in-economic-studies/ 2026-10-01T14:42:45+02:00 https://hebias.be/why-patient-engagement-is-essential-for-market-access-of-medical-innovation-in-belgium/ 2026-10-01T14:42:45+02:00 https://hebias.be/quality-of-life-be-vigilant/ 2026-10-01T14:42:45+02:00 https://hebias.be/managed-entry-agreements-valuable-or-not/ 2026-10-01T14:42:45+02:00 https://hebias.be/separate-or-hybrid-economic-models/ 2026-10-01T14:42:45+02:00 https://hebias.be/indirect-medical-costs/ 2026-10-01T14:42:45+02:00 https://hebias.be/managing-uncertainty-via-deterministic-sensitivity-analysis/ 2026-10-01T14:42:45+02:00 https://hebias.be/most-favoured-nation/ 2026-08-27T21:38:48+02:00 https://hebias.be/willingness-to-pay-in-belgium-a-call-for-clarity-and-evolution/ 2026-04-30T14:10:56+02:00 https://hebias.be/ai-in-healthcare-opportunities-risks/ 2024-03-16T15:24:43+01:00 https://hebias.be/model-hygiene/ 2023-10-27T13:45:07+02:00 https://hebias.be/willingness-to-pay-wtp-versus-medical-need/ 2023-07-28T08:44:09+02:00 https://hebias.be/cost-minimalization-model/ 2023-04-28T11:03:46+02:00 https://hebias.be/how-to-deal-with-uncertainties/ 2023-02-13T15:30:41+01:00 https://hebias.be/the-value-of-net-monetary-benefit/ 2022-10-27T13:12:52+02:00 https://hebias.be/how-to-compare-2-data-sets/ 2022-08-19T17:20:45+02:00 https://hebias.be/health-state-transition-models/ 2022-07-01T15:22:07+02:00 https://hebias.be/the-impact-of-the-procedural-choice-on-the-estimated-launch-date/ 2022-06-09T10:05:50+02:00 https://hebias.be/inflation-vs-discount/ 2022-05-12T16:37:04+02:00 https://hebias.be/earlyaccess/ 2022-04-21T12:29:41+02:00 https://hebias.be/quality-the-key-to-success/ 2022-04-07T07:45:50+02:00 https://hebias.be/66975/ 2022-01-27T16:35:11+01:00 https://hebias.be/epidemiology-data-the-creation-of-spot-on-assessments/ 2021-11-09T13:55:29+01:00 https://hebias.be/how-to-extrapolate-a-limited-data-set/ 2021-08-12T14:18:10+02:00 https://hebias.be/how-to-manage-the-costs-of-adverse-events-in-a-ce-analysis/ 2021-08-01T10:00:09+02:00 https://hebias.be/36703/ 2021-07-07T21:30:28+02:00 https://hebias.be/blog-2-market-access/ 2021-05-27T06:57:35+02:00 https://hebias.be/blog-1-introduction/ 2021-05-20T11:50:43+02:00